8/5/2020 7:15:55 AM
Teva, Alvotech Enter Into Strategic Partnership For Commercialization In U.S. Of Five Biosimilar Product Candidates
8/5/2020 7:03:55 AM
Teva Pharma Q2 GAAP EPS $0.13; Non-GAAP EPS $0.55
7/30/2020 3:09:38 AM
Teva Announces New Strategy For Its Local Commercial Operations
7/29/2020 8:03:36 AM
Teva Reports New Drug Application Filing In Japan For AJOVY (fremanezumab) Injection
7/13/2020 8:03:43 AM
Teva Reports Availability Of ProAir Digihaler Inhalation Powder For Patients With Asthma And COPD
6/18/2020 8:05:04 AM
Teva Presents Analyses Examining Changes In Migraine Disability Outcome Measurements With AJOVY Injection
5/26/2020 8:04:29 AM
Teva's Virtual 2020 Annual Meeting To Be Held On June 9
5/25/2020 2:04:29 AM
Teva Pharma Presents New Data On AJOVY At EAN Congress In Populations With Difficult-to-Treat Migraine
5/22/2020 2:16:27 AM
Teva To Present New AJOVY Analyses And Latest COPAXONE Data
5/18/2020 7:05:27 AM
Teva Says China Approves AUSTEDO For Chorea Associated With Huntington's Disease And Tardive Dyskinesia In Adults
5/7/2020 7:03:52 AM
Teva Q1 GAAP EPS $0.06; Non-GAAP EPS $0.76
5/4/2020 8:04:42 AM
Teva Pharma USA, Celltrion Healthcare Unveil Launch Of TRUXIMA Injection For Rheumatoid Arthritis